SIRS-Lab GmbH Jena | Unique Molecular Diagnostics

SIRS-Lab produces molecular diagnostic test-systems to identify life-threatening infections. The main objective is to enable early and targeted antibiotic therapy of sepsis, a leading cause of death in hospitals. With expert knowledge in critical care medicine, microbiology, assay design, and gene expression, SIRS-Lab builds a unique diagnostic portfolio.

20.05.09
Septic arthritis: Pathogen identification in synovial fluid improved - Paper available
Septic arthritis is a critical condition caused by microbial infections. High mortality can be prevented by early and precise pathogen identification. In a recent study, the pathogen test VYOO was applied to synovial fluid and identified joint infections that can remain undetected by other standard methods.
read more »

07.05.09
Frost & Sullivan Award reinforces SIRS-Lab product strategy for molecular diagnostics
The recipient company has optimised its product line by leveraging products with the various price, performance, and feature points required by one or more market segments.
read more »

molecular diagnostic test for rapid and reliable
pathogen detection
now CE IVD approved